OTCMKTS:GLAPY Glanbia (GLAPY) Stock Price, News & Analysis $123.07 0.00 (0.00%) As of 09/25/2026 Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartDividendNews and TrendsShort Interest About Glanbia Stock (OTCMKTS:GLAPY) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Glanbia alerts:Sign Up Key Stats Today's Range$123.07▼$123.0750-Day Range$123.07▼$143.5052-Week Range$79.41▼$143.50Volume6 shsAverage Volume32 shsMarket Capitalization$5.88 billionP/E RatioN/ADividend Yield1.30%Price TargetN/AConsensus RatingHold Company Overview Glanbia plc is an Ireland-based global nutrition company that develops and manufactures branded consumer products and nutritional ingredients. Its portfolio serves the sports nutrition, lifestyle nutrition, health and wellness, and food and beverage industries. Through its performance nutrition business, Glanbia offers products such as protein powders, bars, ready-to-drink beverages, supplements and other sports nutrition products. Its brands include Optimum Nutrition, Isopure, BSN and Amazing Grass. The company also supplies dairy and non-dairy nutritional ingredients, including protein solutions, premixes and specialized formulations used by food, beverage and nutrition manufacturers. Glanbia has roots in Ireland’s dairy industry and was formed in 1997 through the merger of Avonmore Foods and Waterford Foods. The company serves customers in markets across North America, Europe, Asia and other international regions, with manufacturing, research and commercial operations in several countries. Hugh McGuire has served as Glanbia’s group managing director and chief executive officer since 2024.AI Generated. May Contain Errors. Read More Glanbia Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks9th Percentile Overall ScoreGLAPY MarketRank™: Glanbia scored higher than 9% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.0 / 5Analyst RatingHold Consensus RatingGlanbia has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, no buy ratings, 2 hold ratings, and no sell ratings.Amount of Analyst CoverageGlanbia has received no research coverage in the past 90 days.Read more about Glanbia's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Book Value per Share RatioGlanbia has a P/B Ratio of 3.11. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.00% of the float of Glanbia has been sold short.Short Interest Ratio / Days to CoverGlanbia has a short interest ratio ("days to cover") of 7.3.Change versus previous monthShort interest in Glanbia has recently decreased by 27.72%, indicating that investor sentiment is improving significantly. Dividend0.8 / 5Dividend StrengthWeak Dividend YieldGlanbia pays a meaningful dividend of 1.30%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthGlanbia does not have a long track record of dividend growth.Read more about Glanbia's dividend. News and Social MediaN/ANews SentimentN/A Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Glanbia insiders have not sold or bought any company stock.Percentage Held by Insiders0.82% of the stock of Glanbia is held by insiders.Percentage Held by InstitutionsGlanbia has minimal institutional ownership at this time.Read more about Glanbia's insider trading history. Receive GLAPY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Glanbia and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. GLAPY Stock News HeadlinesGlanbia hikes profit forecast as weight-loss drugs boost demand for protein productsAugust 6, 2026 | reuters.comGlanbia PLC ADR GLAPYJuly 8, 2026 | morningstar.comMMajor Buy Alert Issued for September 30thKeith Kaplan has invested $17 million into his own AI research tools, building a platform now used by 180,000 people worldwide. His system has flagged a handful of stocks worth watching ahead of September 30th. See which stocks his AI research platform is flagging right now.September 26 at 1:00 AM | TradeSmith (Ad)Glanbia Stock More Than Doubles as Protein Demand May Rise 37%June 19, 2026 | finance.yahoo.comGlanbia Plc ADR (GLAPY) SEC FilingsMay 22, 2026 | nasdaq.comGlanbia plc (GLAPY) Q4 2025 Earnings Call TranscriptFebruary 25, 2026 | seekingalpha.comGlanbia plc (GLAPY) Analyst/Investor Day TranscriptNovember 20, 2025 | seekingalpha.comGlanbia plc (GLAPY) Q3 2025 Earnings Call TranscriptNovember 5, 2025 | seekingalpha.comSee More Headlines GLAPY Stock Analysis - Frequently Asked Questions How have GLAPY shares performed this year? Glanbia's stock was trading at $86.47 at the beginning of the year. Since then, GLAPY stock has increased by 42.3% and is now trading at $123.07. How do I buy shares of Glanbia? Shares of GLAPY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today9/26/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorConsumer Staples Industry FOOD - DAIRY PRDS Sub-IndustryN/A Current SymbolOTCMKTS:GLAPY Previous SymbolOTC:GLAPY CIKN/A Webwww.glanbia.com Phone353567772200FaxN/AEmployees4,963Year Founded1997Profitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio0.38 Current Ratio1.36 Quick Ratio0.81 Sales & Book Value Annual Sales$3.95 billion Price / Sales1.49 Cash Flow$8.87 per share Price / Cash Flow13.87 Book Value$39.53 per share Price / Book3.11Miscellaneous Outstanding Shares47,780,000Free Float47,391,000Market Cap$5.88 billion OptionableNot Optionable Beta0.12 Social Links Don't Wait for the OpenAI IPOThe AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.Get This Free Report This page (OTCMKTS:GLAPY) was last updated on 9/26/2026 by MarketBeat.com Staff. From Our PartnersA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...Porter & Company | SponsoredI'm giving you a space stock today. Free.On December 8th, $600 billion in frozen SpaceX stock comes loose. Dylan Jovine says one simple purchase in any...Behind the Markets | SponsoredMajor Buy Alert Issued for September 30thKeith Kaplan has invested $17 million into his own AI research tools, building a platform now used by 180,000 ...TradeSmith | SponsoredHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...Banyan Hill Publishing | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | Sponsored6 Elon Musk companies. The 1 FREE investor roadmap to them all.Elon Musk owns six companies, but most investors can only access four. Tesla, SpaceX, xAI, and X are public an...Zacks | Sponsored"How Much Can I Actually Spend Each Year With $2.5M Saved?"Having $2.5 million saved puts you ahead of most Americans, but how long it lasts depends on the decisions you...SmartAsset | SponsoredBank of America: 'Digital Dollar Inevitable'Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...Decentralized Masters | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Glanbia Plc ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Glanbia With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.